Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A

Immunologic Research

Volumn 57, Issue 1-3, 2013, Pages 258-267

  Rolle, Cleo E ^a   Chen, Juan ^a   Pastar, Irena ^a   Cardenas, Tatiana C P ^a   Perez, Roberto ^a   Hower, Suzanne ^a   Ferracci, Franco ^a   Snyder, Richard ^a   Tomic Canic, Marjana ^a   Plano, Lisa R W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Desmoglein 1; Exfoliative toxins; IL 6; Keratinocyte; Staphylococcus aureus

Indexed keywords

DESMOGLEIN 1; EXFOLIATIN; INTERLEUKIN 6; PANTON VALENTINE LEUKOCIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; KERATINOCYTE; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; CELL LINE; DESMOGLEIN 1; EPIDERMIS; EXFOLIATINS; HUMANS; INTERLEUKIN-6; KERATINOCYTES; LEUKOCYTES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROTEOLYSIS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84891484676     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8467-y     Document Type: Article

References (49)

1. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-6.
2. Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis. 2006;12(12):1991-3. doi: 10.3201/eid1212.060505.
3. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-71. doi: 10.1001/jama.298.15.1763.
4. Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci. 2006;42(3):203-14. doi: 10.1016/j.jdermsci.2006.03.011.
5. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520-32. doi: 10.1056/NEJM199808203390806.
6. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-74. doi: 10.1056/NEJMoa055356.
7. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006;193(11):1495-503. doi: 10.1086/503777.
8. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3(12):948-58. doi: 10.1038/nrmicro1289.
9. Couppie P, Cribier B, Prevost G. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol. 1994;130(9):1208-9.
10. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128-32. doi: 10.1086/313461.
11. Yamasaki O, Kaneko J, Morizane S, Akiyama H, Arata J, Narita S, et al the association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis. 2005;40(3):381-5. doi: 10.1086/427290.
12. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315(5815):1130-3. doi: 10.1126/science.1137165.
13. Kawabata A, Ichiyama S, Iinuma Y, Hasegawa Y, Ohta M, Shimokata K. Exfoliative toxin detection using reversed passive latex agglutination: clinical and epidemiologic applications. J Clin Microbiol. 1997;35(8):1984-7.
14. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med. 2000;6(11):1275-7. doi: 10.1038/81385.
15. Harmon RM, Simpson CL, Johnson JL, Koetsier JL, Dubash AD, Najor NA, et al. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation. J Clin Invest. 2013;123(4):1556-70. doi: 10.1172/JCI65220.
16. Plano LR, Adkins B, Woischnik M, Ewing R, Collins CM. Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model. Infect Immun. 2001;69(8):5193-7. doi: 10.1128/IAI.69.8.5193- 5197.2001.
17. Mertz PM, Cardenas TC, Snyder RV, Kinney MA, Davis SC, Plano LR. Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol. 2007;143(10):1259-63. doi: 10.1001/archderm.143.10.1259.
18. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155-61.
19. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol. 1999;37(11):3556-63.
20. Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41(12):5442-8.
21. Hower S, Phillips MC, Brodsky M, Dameron A, Tamargo MA, Salazar NC, et al. Clonally related methicillin-resistant Staphylococcus aureus isolated from short-finned pilot whales (Globicephala macrorhynchus), human volunteers, and a bayfront cetacean rehabilitation facility. Microb Ecol. 2013;65(4):1024-38. doi: 10.1007/s00248-013-0178-3.
22. Plano LR, Shibata T, Garza AC, Kish J, Fleisher JM, Sinigalliano CD, et al. Human-associated methicillin-resistant Staphylococcus aureus from a subtropical recreational marine beach. Microb Ecol. 2013;65(4):1039-51. doi: 10.1007/s00248-013-0216-1.
23. Plano LR, Gutman DM, Woischnik M, Collins CM. Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens. Infect Immun. 2000;68(5):3048-52.
24. Randolph RK, Simon M. Characterization of retinol metabolism in cultured human epidermal keratinocytes. J Biol Chem. 1993;268(13):9198-205.
25. Jho SH, Vouthounis C, Lee B, Stojadinovic O, Im MJ, Brem H, et al the book of opposites: the role of the nuclear receptor co-regulators in the suppression of epidermal genes by retinoic acid and thyroid hormone receptors. J Invest Dermatol. 2005;124(5):1034-43. doi: 10.1111/j.0022-202X.2005.23691.x.
26. Pastar I, Stojadinovic O, Krzyzanowska A, Barrientos S, Stuelten C, Zimmerman K, et al. Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med. 2010;16(3-4):92-101. doi: 10.2119/molmed.2009.00149.
27. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7): RESEARCH0034.
28. McDonald RR, Golding GR, Irvine J, Graham MR, Tyler S, Mulvey MR, et al. Draft Genome Sequence of Methicillin-Susceptible Staphylococcus aureus Strain 06BA18369, a Pathogen Associated with Skin and Soft Tissue Infections in Northern Saskatchewan, Canada. Genome Announc. 2013;1(3). doi: 10.1128/genomeA.00389-13.
29. Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol. 1990;94(6 Suppl):101S-7S.
30. Plano LR. Staphylococcus aureus exfoliative toxins: how they cause disease. J Invest Dermatol. 2004;122(5):1070-7. doi: 10.1111/j.1523-1747.2004. 22144.x.
31. Olaru F, Jensen LE. Staphylococcus aureus stimulates neutrophil targeting chemokine expression in keratinocytes through an autocrine IL-1alpha signaling loop. J Invest Dermatol. 2010;130(7):1866-76. doi: 10.1038/jid.2010.37.
32. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101(2):311-20. doi: 10.1172/JCI1368.
33. Dube PH, Handley SA, Lewis J, Miller VL. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect Immun. 2004;72(6):3561-70. doi: 10.1128/IAI.72.6.3561-3570.2004.
34. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol. 2009;183(5):3170-6. doi: 10.4049/jimmunol.0803721.
35. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14(6):705-14.
36. McLoughlin RM, Hurst SM, Nowell MA, Harris DA, Horiuchi S, Morgan LW, et al. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol. 2004;172(9):5676-83.
37. Pastar I, Stojadinovic O, Tomic-Canic M. Role of keratinocytes in healing of chronic wounds. Surg Technol Int. 2008;17:105-12.
38. Pajulo OT, Pulkki KJ, Alanen MS, Reunanen MS, Lertola KK, Mattila-Vuori AI, et al. Correlation between interleukin-6 and matrix metalloproteinase-9 in early wound healing in children. Wound Repair Regen. 1999;7(6):453-7.
39. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, et al. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem. 2005;280(25):23778-84. doi: 10.1074/jbc.M501365200.
40. Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem. 2007;282(18):13804-12. doi: 10.1074/jbc.M611365200.
41. Dusek RL, Godsel LM, Green KJ. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci. 2007;45(1):7-21. doi: 10.1016/j.jdermsci.2006.10.006.
42. Dancer SJ, Noble WC. Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin. J Clin Pathol. 1991;44(8):681-4.
43. Larsen HD, Aarestrup FM, Jensen NE. Geographical variation in the presence of genes encoding superantigenic exotoxins and beta-hemolysin among Staphylococcus aureus isolated from bovine mastitis in Europe and USA. Vet Microbiol. 2002;85(1):61-7.
44. Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B, et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol. 1995;42(4):237-45.
45. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43(5):2384-90. doi: 10.1128/JCM.43.5.2384-2390. 2005.
46. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193(2):172-9. doi: 10.1086/499632.
47. Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun. 2002;70(9):4987-96.
48. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol. 2003;41(4):1434-9.
49. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med. 2004;199(5):687-95. doi: 10.1084/jem. 20031636.